WallStreetZenWallStreetZen

NASDAQ: XOMA
Xoma Royalty Corp Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for XOMA

Based on 2 analysts offering 12 month price targets for Xoma Royalty Corp

Min Forecast
$35.00+2.37%
Avg Forecast
$69.50+103.28%
Max Forecast
$104.00+204.18%

Should I buy or sell XOMA stock?

Based on 2 analysts offering ratings for Xoma Royalty Corp.

Strong Buy
Strong Buy
1 analysts 50%
Buy
1 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Our proven Zen Rating quant model "Buy" agrees with analyst consensus with a "Strong Buy" rating. Learn More

Be the first to know when Wall Street analysts revise their XOMA stock forecasts and price targets.

XOMA stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-05-28
lockedlocked$00.00+00.00%2025-04-17

1 of 1

Forecast return on equity

Is XOMA forecast to generate an efficient return?

Company
69.75%
Industry
122.74%
Market
-47.8%
XOMA's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is XOMA forecast to generate an efficient return on assets?

Company
22.61%
Industry
46.26%
XOMA is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

XOMA earnings per share forecast

What is XOMA's earnings per share in the next 3 years based on estimates from 2 analysts?

Avg 1 year Forecast
$0.88
Avg 2 year Forecast
$0.60
Avg 3 year Forecast
$1.68

XOMA revenue forecast

What is XOMA's revenue in the next 3 years based on estimates from 2 analysts?

Avg 1 year Forecast
$55.1M+22.46%
Avg 2 year Forecast
$61.8M+37.37%
Avg 3 year Forecast
$76.4M+69.96%
XOMA's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

XOMA revenue growth forecast

How is XOMA forecast to perform vs Biotechnology companies and vs the US market?

Company
18.14%
Industry
82.98%
Market
10.98%
XOMA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
XOMA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

XOMA vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
XOMA$34.19$69.50+103.28%Strong Buy
CRVS$5.54$13.00+134.66%Buy
LXRX$1.14$3.23+182.89%Strong Buy
AURA$6.50$22.00+238.46%Buy
IMAB$5.18$6.75+30.31%Buy
View Top Biotech Stocks

Xoma Royalty Stock Forecast FAQ

Is Xoma Royalty Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: XOMA) stock is to Strong Buy XOMA stock.

Out of 2 analysts, 1 (50%) are recommending XOMA as a Strong Buy, 1 (50%) are recommending XOMA as a Buy, 0 (0%) are recommending XOMA as a Hold, 0 (0%) are recommending XOMA as a Sell, and 0 (0%) are recommending XOMA as a Strong Sell.

If you're new to stock investing, here's how to buy Xoma Royalty stock.

What is XOMA's earnings growth forecast for 2025-2027?

(NASDAQ: XOMA) Xoma Royalty's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 5.32%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.39%.

Xoma Royalty's earnings in 2025 is -$12,389,000.On average, 2 Wall Street analysts forecast XOMA's earnings for 2025 to be $10,637,193, with the lowest XOMA earnings forecast at $7,131,754, and the highest XOMA earnings forecast at $14,142,631. On average, 3 Wall Street analysts forecast XOMA's earnings for 2026 to be $7,292,521, with the lowest XOMA earnings forecast at -$2,417,544, and the highest XOMA earnings forecast at $16,197,543.

In 2027, XOMA is forecast to generate $20,307,368 in earnings, with the lowest earnings forecast at $20,307,368 and the highest earnings forecast at $20,307,368.

What is XOMA's revenue growth forecast for 2025-2027?

(NASDAQ: XOMA) Xoma Royalty's forecast annual revenue growth rate of 18.14% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 82.98%, and while it is forecast to beat the US market's average forecast revenue growth rate of 10.98%.

Xoma Royalty's revenue in 2025 is $44,952,000.On average, 2 Wall Street analysts forecast XOMA's revenue for 2025 to be $665,428,931, with the lowest XOMA revenue forecast at $626,143,844, and the highest XOMA revenue forecast at $704,714,018. On average, 2 Wall Street analysts forecast XOMA's revenue for 2026 to be $746,416,648, with the lowest XOMA revenue forecast at $704,714,018, and the highest XOMA revenue forecast at $788,119,279.

In 2027, XOMA is forecast to generate $923,501,732 in revenue, with the lowest revenue forecast at $923,501,732 and the highest revenue forecast at $923,501,732.

What is XOMA's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: XOMA) forecast ROA is 22.61%, which is lower than the forecast US Biotechnology industry average of 46.26%.

What is XOMA's Price Target?

According to 2 Wall Street analysts that have issued a 1 year XOMA price target, the average XOMA price target is $69.50, with the highest XOMA stock price forecast at $104.00 and the lowest XOMA stock price forecast at $35.00.

On average, Wall Street analysts predict that Xoma Royalty's share price could reach $69.50 by May 28, 2026. The average Xoma Royalty stock price prediction forecasts a potential upside of 103.28% from the current XOMA share price of $34.19.

What is XOMA's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: XOMA) Xoma Royalty's current Earnings Per Share (EPS) is -$1.52. On average, analysts forecast that XOMA's EPS will be $0.88 for 2025, with the lowest EPS forecast at $0.59, and the highest EPS forecast at $1.17. On average, analysts forecast that XOMA's EPS will be $0.60 for 2026, with the lowest EPS forecast at -$0.20, and the highest EPS forecast at $1.34. In 2027, XOMA's EPS is forecast to hit $1.68 (min: $1.68, max: $1.68).

What is XOMA's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: XOMA) forecast ROE is 69.75%, which is considered strong.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.